Edition:
United Kingdom

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.40USD
5:55pm GMT
Change (% chg)

$-0.08 (-1.79%)
Prev Close
$4.48
Open
$4.30
Day's High
$4.68
Day's Low
$4.29
Volume
11,355
Avg. Vol
8,569
52-wk High
$8.56
52-wk Low
$3.58

Chart for

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $56.33
Shares Outstanding(Mil.): 10.04
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Avenue Therapeutics reports Q3 loss per share $0.30

* Avenue Therapeutics Inc reports third quarter 2017 financial results and recent corporate highlights

09 Nov 2017

BRIEF-Avenue therapeutics reports Q2 loss per share $0.70

* Avenue Therapeutics reports second quarter 2017 financial results and recent corporate highlights

11 Aug 2017

Earnings vs. Estimates

No consensus analysis data available.